🇺🇸 FDA
Patent

US 11458210

Compounds and compositions for targeting brain injuries and methods of use thereof

granted A61KA61K47/62A61K47/6425

Quick answer

US patent 11458210 (Compounds and compositions for targeting brain injuries and methods of use thereof) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Grant date
Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K47/62, A61K47/6425, A61K47/6923, A61K47/6929